How Journals Treat Papers from Researchers Who Committed Misconduct

Nature Plants explains how it handled a manuscript coauthored by Patrice Dunoyer, a biologist with multiple retractions to his name.

Written byDiana Kwon
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, BRIANAJACKSONIn June, Nature Plants published a manuscript by Patrice Dunoyer, a plant biologist at the French National Centre for Scientific Research (CNRS) in France who was previously found guilty of scientific misconduct. The paper, which describes a strategy used by viruses to suppress a host plant’s defences, was published along with an editorial describing Dunoyer’s previous retractions and stating that since subsequent disciplinary action was taken, this author’s paper was treated like any other submission.

Dunoyer was part of a troubled plant biology group led by Olivier Voinnet, a high-profile scientist known for his work on RNA inference in plants. That team, which was based at the CNRS, had eight papers retracted from several journals, including Science, The EMBO Journal, and Plant Cell, and more than 20 corrected due to image duplications and manipulations.

After investigations by the CNRS and the Swiss Federal Institute of Technology (ETH) Zurich (where Voinnet is currently employed) independently uncovered evidence of image manipulation in 2015, Voinnet received a three-year funding ban from the Swiss National Science Foundation, a two-year suspension from the CNRS, and had an award revoked by EMBO. Dunoyer, who was a first author on a number of the retracted papers, also ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies